CDK7 and breast carcinoma: CDK14 has been shown to interact with other cyclins as well, such as cyclin B to activate the Wnt pathway in breast cancer [35], cyclin D3 to regulate cell cycle progression and proliferation in mammalian cells [36], and the CDK7/cyclin H complex to regulate proliferation and migration in esophageal cancer [37].